Tailored Supplemental Screening for Breast Cancer: What Now and What Next?
- 1 February 2009
- journal article
- review article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 192 (2), 390-399
- https://doi.org/10.2214/ajr.08.1706
Abstract
OBJECTIVE. This article reviews breast cancer risk assessment and the rationale for current screening guidelines, including when to consider using supplemental screening with MRI or sonography in addition to mammography, and discusses other emerging technologies. Radiologists can help identify women who may benefit from supplemental screening and can help to recommend when and which techniques to perform for this additional screening. CONCLUSION. Mammography remains the mainstay of breast cancer screening. Mammography should be performed as digital imaging when possible in women with dense breasts. In women at high risk, particularly if they also have dense breasts, annual MRI is recommended, although further validation of outcomes is needed. In intermediate-risk women with dense breasts, especially those with other risk factors, and in high-risk women with dense breasts who are unable to tolerate MRI, supplemental sonography screening is an option at facilities with availability of qualified personnel. Developing technologies are not appropriate for screening at this time, although further study is encouraged.Keywords
This publication has 72 references indexed in Scilit:
- Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast CancerJama-Journal Of The American Medical Association, 2008
- Breast cancer risk-assessment modelsBreast Cancer Research, 2007
- American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to MammographyCA: A Cancer Journal for Clinicians, 2007
- Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast CancerJournal of Clinical Oncology, 2005
- Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinicsJournal of Medical Genetics, 2003
- American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer SusceptibilityJournal of Clinical Oncology, 2003
- Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight CohortsRadiation Research, 2002
- Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the diseaseThe Lancet, 2001
- Mammographic screening of the high-risk womanThe American Journal of Surgery, 2000
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998